Heron Therapeutics (HRTX)'s 30-day implied volatility (IV30) was 92.9% at the close on November 10, 2026, up from 85.5% the day before, against a 52-week range of 44.0% to 198.6%. Its 20-day historical volatility was 102.5%.
Data as of November 10, 2026.